Australia's largest stock trading and investment forum Australia's #1 stock forum

MYX

Click for more information

3.25%

$4.77 mayne pharma group limited

Ann: 2024 Half Year Investor Presentation, page-120

First 120 Last

Share
Profile

Follow
Patrick31

1,345 Posts.

263

17/03/24

12:31

Post #: 72926925
Share

Originally posted by Hiddenvalue: ↑

For the reasons of the large launch costs and investment required, I can't see competition in a bid for the product.

The other consideration is the product is not even approved yet in US??

Mithra need cash and quickly. If MYX board are in discussions we need to remind Mithra board that we now dictate any offer as we are keeping them out of insolvency.

Expand

Should FDA approval be anything like
the Nuvaring debacle. Best we leave it
alone.

MYX Price at posting: $6.76 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 21 more messages in this thread...

First 120 Last

Add MYX (ASX) to my watchlist

(20min delay)
Last $4.77		Change -0.160(3.25%)		Mkt cap ! $405.8M

Open	High	Low	Value	Volume
$4.94	$5.02	$4.75	$1.848M	380.8K

Buyers (Bids)

No.	Vol.	Price($)
2	4114	$4.77

Sellers (Offers)

Price($)	Vol.	No.
$4.80	109	1

View Market Depth

No.	Vol.	Price($)
2	4114	4.770
5	15081	4.760
2	4846	4.750
1	846	4.740
1	846	4.730

Price($)	Vol.	No.
4.800	109	1
4.810	109	1
4.820	109	1
4.830	109	1
4.840	109	1

Last trade - 16.10pm 06/06/2024 (20 minute delay)


Last $4.79			Change -0.160 ( 2.42 %)
Open	High		Low	Volume
$4.98	$5.02		$4.75	100660
Last updated 15.59pm 06/06/2024 ?

MYX (ASX) Chart